These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 29492965

  • 1. A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands.
    Boon E, Bel M, van Boxtel W, van der Graaf WTA, van Es RJJ, Eerenstein SEJ, Baatenburg de Jong RJ, van den Brekel MWM, van der Velden LA, Witjes MJH, Hoeben A, Willems SM, Bloemena E, Smit LA, Oosting SF, PALGA Group, Jonker MA, Flucke UE, van Herpen CML.
    Int J Cancer; 2018 Aug 15; 143(4):758-766. PubMed ID: 29492965
    [Abstract] [Full Text] [Related]

  • 2. Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : A monocentric clinicopathologic analysis.
    Haderlein M, Scherl C, Semrau S, Lettmaier S, Hecht M, Erber R, Iro H, Fietkau R, Agaimy A.
    Strahlenther Onkol; 2017 Nov 15; 193(11):961-970. PubMed ID: 28828496
    [Abstract] [Full Text] [Related]

  • 3. A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.
    Gilbert MR, Sharma A, Schmitt NC, Johnson JT, Ferris RL, Duvvuri U, Kim S.
    JAMA Otolaryngol Head Neck Surg; 2016 May 01; 142(5):489-95. PubMed ID: 26939990
    [Abstract] [Full Text] [Related]

  • 4. Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma.
    Masubuchi T, Tada Y, Maruya S, Osamura Y, Kamata SE, Miura K, Fushimi C, Takahashi H, Kawakita D, Kishimoto S, Nagao T.
    Int J Clin Oncol; 2015 Feb 01; 20(1):35-44. PubMed ID: 24553861
    [Abstract] [Full Text] [Related]

  • 5. Prognostic factors and outcome analysis of salivary duct carcinoma.
    Han MW, Roh JL, Choi SH, Nam SY, Lee HJ, Cho KJ, Lee SW, Kim SY.
    Auris Nasus Larynx; 2015 Dec 01; 42(6):472-7. PubMed ID: 26028371
    [Abstract] [Full Text] [Related]

  • 6. The extent of androgen receptor and HER2 expression allows for targeted therapy in most cases of salivary duct carcinoma: analysis of clinical and histopathological data in a tertiary care center.
    Mayer M, Wolber P, Prinz J, Jansen L, Esser J, Shabli S, Quaas A, Klußmann JP, Sharma SJ, Nachtsheim L, Arolt C.
    Eur Arch Otorhinolaryngol; 2024 Jul 01; 281(7):3779-3789. PubMed ID: 38587651
    [Abstract] [Full Text] [Related]

  • 7. Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients.
    Williams MD, Roberts D, Blumenschein GR, Temam S, Kies MS, Rosenthal DI, Weber RS, El-Naggar AK.
    Am J Surg Pathol; 2007 Nov 01; 31(11):1645-52. PubMed ID: 18059220
    [Abstract] [Full Text] [Related]

  • 8. Parotid salivary duct carcinoma: a single institution's 20-year experience.
    Stodulski D, Mikaszewski B, Majewska H, Kuczkowski J.
    Eur Arch Otorhinolaryngol; 2019 Jul 01; 276(7):2031-2038. PubMed ID: 31062093
    [Abstract] [Full Text] [Related]

  • 9. Invasive micropapillary salivary duct carcinoma: a distinct histologic variant with biologic significance.
    Nagao T, Gaffey TA, Visscher DW, Kay PA, Minato H, Serizawa H, Lewis JE.
    Am J Surg Pathol; 2004 Mar 01; 28(3):319-26. PubMed ID: 15104294
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of PSMA, c-MET and E-cadherin in salivary duct carcinoma.
    van Boxtel W, Uijen MJM, Verhaegh GW, Willems SM, Jonker MA, PALGA Group, Schalken JA, van Engen-van Grunsven ICH, van Herpen CML.
    Oral Oncol; 2020 Nov 01; 110():105018. PubMed ID: 33039794
    [Abstract] [Full Text] [Related]

  • 11. [Survival analysis and immunohistochemical study of HER-2 and AR (androgen receptor) expression in salivary duct carcinoma].
    Otsuka K, Imanishi Y, Habu N, Sato Y, Shigetomi S, Fujii R, Sakamoto K, Tomita T, Fujii M, Kameyama K, Ogawa K.
    Nihon Jibiinkoka Gakkai Kaiho; 2013 Sep 01; 116(9):1024-32. PubMed ID: 24191589
    [Abstract] [Full Text] [Related]

  • 12. Androgen receptor immunohistochemistry in salivary duct carcinoma: a retrospective study of 188 cases focusing on tumoral heterogeneity and temporal concordance.
    Xu B, Dogan S, Haroon Al Rasheed MR, Ghossein R, Katabi N.
    Hum Pathol; 2019 Nov 01; 93():30-36. PubMed ID: 31430492
    [Abstract] [Full Text] [Related]

  • 13. Survival rates and prognostic factors for infiltrating salivary duct carcinoma: Analysis of 228 cases from the Surveillance, Epidemiology, and End Results database.
    Jayaprakash V, Merzianu M, Warren GW, Arshad H, Hicks WL, Rigual NR, Sullivan MA, Seshadri M, Marshall JR, Cohan DM, Zhao Y, Singh AK.
    Head Neck; 2014 May 01; 36(5):694-701. PubMed ID: 23606370
    [Abstract] [Full Text] [Related]

  • 14. Systemic therapy in the management of recurrent or metastatic salivary duct carcinoma: A systematic review.
    Uijen MJM, Lassche G, van Engen-van Grunsven ACH, Tada Y, Verhaegh GW, Schalken JA, Driessen CML, van Herpen CML.
    Cancer Treat Rev; 2020 Sep 01; 89():102069. PubMed ID: 32717621
    [Abstract] [Full Text] [Related]

  • 15. Clinicopathological features and treatment outcomes of the rare, salivary duct carcinoma of parotid gland.
    Al-Qahtani KH, Tunio MA, Bayoumi Y, Gurusamy VM, Bahamdain FA, Fatani H.
    J Otolaryngol Head Neck Surg; 2016 May 16; 45(1):32. PubMed ID: 27184361
    [Abstract] [Full Text] [Related]

  • 16. Cervical Lymph Node Metastatic Status and Adjuvant Therapy Predict the Prognosis of Salivary Duct Carcinoma.
    Qian K, Di L, Guo K, Zheng X, Ji Q, Wang Z.
    J Oral Maxillofac Surg; 2018 Jul 16; 76(7):1578-1586. PubMed ID: 29544756
    [Abstract] [Full Text] [Related]

  • 17. Salivary duct carcinoma.
    D'heygere E, Meulemans J, Vander Poorten V.
    Curr Opin Otolaryngol Head Neck Surg; 2018 Apr 16; 26(2):142-151. PubMed ID: 29373327
    [Abstract] [Full Text] [Related]

  • 18. Salivary duct carcinoma: Clinicopathologic features, morphologic spectrum, and somatic mutations.
    Luk PP, Weston JD, Yu B, Selinger CI, Ekmejian R, Eviston TJ, Lum T, Gao K, Boyer M, O'Toole SA, Clark JR, Gupta R.
    Head Neck; 2016 Apr 16; 38 Suppl 1():E1838-47. PubMed ID: 26699379
    [Abstract] [Full Text] [Related]

  • 19. Salivary duct carcinoma: Prospective multicenter study of 61 cases of the Réseau d'Expertise Français des Cancers ORL Rares.
    Villepelet A, Lefèvre M, Verillaud B, Janot F, Garrel R, Vergez S, Bertolus C, Malard O, de Gabory L, Mauvais O, Baujat B, REFCOR membersRéseau d'Expertise Français des Cancers ORL Rares: (REFCOR, French Rare Head and Neck Cancer Expert Network): S. Albert, G. Andry, E. Babin, C. Bach, J.-M. Badet, C. Badoual, A.C. Baglin, A. Banal, B. Barry, E. Baudin, B. Baujat, R.J. Bensadoun, C. Bertolus, J.-P. Bessède, D. Blanchard, C. Borel, A. Bozorg-Grayeli, R. Breheret, P. Breton, L. Brugel, G. Calais, O. Casiraghi, E. Cassagnau, L. Castillo, P. Ceruse, F. Chabolle, D. Chevalier, J.C. Chobaut, O. Choussy, A. Cosmidis, A. Coste, V. Costes, L. Crampette, V. Darrouzet, P. Demez, P. Dessi, B. Devauchelle, G. Dolivet, F. Dubrulle, S. Duflo, X. Dufour, S. Faivre, N. Fakhry, C. Ferron, F. Floret, L. de Gabory, R. Garrel, L. Geoffrois, L. Gilain, A. Giovanni, A. Girod, B. Guerrier, S. Hans, P. Herman, P. Hofman, M. Housset, R. Jankowski, F. Jegoux, M. Juliéron, M.-C. Kaminsky, F. Kolb, J. Lacau St Guily, L. Laccoureye, B. Lallemant, P. Lang, E. Lartigau, J.-P. Lavieille, M. Lefevre, X. Leroy, O. Malard, F. Massip, O. Mauvais, J.-C. Merol, J. Michel, T. Mom, S. Morinière, E. de Monès, G. Moulin, G. Noel, G. Poissonnet, J.-M. Prades, D. de Raucourt, E. Reyt, C. Righini, Y. Marie Robin, F. Rolland, B. Ruhin, N. Sarroul, P. Schultz, E. Serrano, O. Sterkers, V. Strunski, A. Sudaka, M. Tassart, S. Testelin, J. Thariat, A. Timochenko, B. Toussaint, E. Uro Coste, G. Valette, T. Van den Abbeele, A. Varoquaux, F. Veillon, S. Vergez, M. Wassef..
    Head Neck; 2019 Mar 16; 41(3):584-591. PubMed ID: 30421824
    [Abstract] [Full Text] [Related]

  • 20. Biomarker immunoprofile and molecular characteristics in salivary duct carcinoma: clinicopathological and prognostic implications.
    Santana T, Pavel A, Martinek P, Steiner P, Grossmann P, Baněčková M, Skálová A.
    Hum Pathol; 2019 Nov 16; 93():37-47. PubMed ID: 31437521
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.